Text Size
24 studies found for:    " March 31, 2010":" April 30, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
" March 31, 2010":" April 30, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown † Injecting Drug Use Community Intervention Trial
Conditions: HIV;   Hepatitis C;   Syphilis;   HSV-2;   HIV Infections
Intervention: Behavioral: Intervention
2 Not yet recruiting Adherence to HIV Therapy in Heroin Addicts
Conditions: HIV;   Substance Abuse;   HIV Infections
Interventions: Drug: Oral Naltrexone (ON);   Drug: Implantable Naltrexone (IN)
3 Active, not recruiting Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of GS-9350-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Adults
Conditions: HIV;   HIV Infections
Interventions: Drug: GS-9350 + atazanavir + emtricitabine/tenofovir DF;   Drug: Comparator: ritonavir + atazanavir + emtricitabine/tenofovir DF
4 Active, not recruiting
Has Results 		Study to Evaluate the Safety and Efficacy of Stribild Versus Ritonavir-Boosted Atazanavir Plus Truvada in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults
Conditions: HIV;   HIV Infections
Interventions: Drug: Stribild;   Drug: ATV/r + Truvada
5 Recruiting International HIV Antiretroviral Adherence, Resistance and Survival
Condition: HIV/AIDS
Intervention:
6 Unknown † Neurocognitive Effects of Buprenorphine Among HIV+ and HIV-Opioid Users
Conditions: Opioid-Related Disorders;   Buprenorphine;   HIV;   Cognition;   HIV Infections
Intervention:
7 Completed PK of Tenofovir, Emtricitabine and Efavirenz in Healthy Volunteers
Conditions: HIV Infection;   HIV Infections
Intervention: Drug: Atripla®
8 Active, not recruiting The Impact of Short-term Financial Incentives on Sexual Behavior and HIV Incidence in Lesotho
Conditions: AIDS/HIV PROBLEM;   Sexually Transmitted Diseases
Intervention: Behavioral: Financial incentive through lotteries
9 Completed Project POWER, Adapting Project SAFE: Reducing STD/HIV Risk in Women Prisoners
Condition: HIV Infections
Interventions: Behavioral: Project POWER HIV Risk-reduction Intervention;   Behavioral: NC DOC Standard of Care for STIs
10 Completed H1N1 Influenza Vaccine Immunogenicity in HIV-1 Infected Patients
Condition: HIV Infections
Intervention: Biological: H1N1 vaccination
11 Unknown † A Trial to Test the Efficacy of a Tailored Intensive Smoking Cessation Intervention in Persons With HIV (PWHs)
Conditions: Smoking;   HIV Infections;   AIDS
Interventions: Behavioral: Positively Smoke Free;   Behavioral: Standard care
12 Completed Extended Follow-Up of Participants in Preventive HIV Vaccine Studies in Uganda
Condition: HIV Infections
Intervention:
13 Unknown † Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: Raltegravir;   Drug: Atazanavir/Ritonavir
14 Unknown † Heart Function in HIV-Negative Children Exposed to HIV and HAART
Condition: HIV Infections
Intervention:
15 Enrolling by invitation Test of an Intervention to Improve HIV Care
Condition: HIV Infection
Interventions: Behavioral: Patient Mentor Intervention;   Behavioral: HIV transmission risk reduction
16 Active, not recruiting PRINCE: Study of Atazanavir (ATV)/Ritonavir (RTV)
Condition: HIV Infections
Interventions: Drug: Atazanavir;   Drug: Ritonavir
17 Active, not recruiting Evaluating the Safety and Immune Response of an Adenovirus-Based HIV Vaccine in HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: Ad26.ENVA.01 (rAd26);   Biological: Placebo Vaccine
18 Unknown † Safety Study of Isentress® + Truvada® in Post-exposure Treatment of HIV Infection
Condition: HIV Infections
Interventions: Drug: raltegravir (Isentress);   Drug: Truvada®
19 Active, not recruiting
Has Results 		A Simplification Study of Unboosted Reyataz With Epzicom (ASSURE)
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Reyataz + Norvir + Truvada;   Drug: Reyataz + Epzicom
20 Completed A Drug Interaction Study Evaluating GSK2248761 and Raltegravir Pharmacokinetics in Healthy Adult Subjects
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: GSK2248761;   Drug: GSK2248761 + Raltegravir
To Top

Previous Page Studies Shown (1-20) Next Page (21-24) Show next page of results
† Indicates status has not been verified in more than two years